SYSCAN INTERNATIONAL INC.
TSX VENTURE : SYA

SYSCAN INTERNATIONAL INC.

November 09, 2007 13:47 ET

Syscan Terminates Agreement With Alternatives Technologie Pharma

MONTREAL, CANADA--(Marketwire - Nov. 9, 2007) - Syscan International Inc. ("Syscan") (TSX VENTURE:SYA) today announced that the proposed acquisition of Alternatives Technologie Pharma ("ATP"), originally announced on October 2, 2007, has been mutually terminated between the parties following an extensive due diligence. Syscan, in particular, concluded that it would not be in the best interests of its shareholders to proceed with this transaction.

Mr. Joseph Tassone, President and CEO of Syscan said, "Despite the termination of this agreement, we will keep building our business relationship with ATP to grow sales in the life sciences area. We expect strong growth in 2008 as Syscan's aggressive acquisition strategy continues to unfold. Preliminary results for the 1st quarter of FY 2008 are strong, showing marked increase in revenues and significant improvements in operating results. We expect to continue with other acquisitions from other relationships we have been actively cultivating and processing."

The shares of Syscan are expected to resume trading shortly on TSX Venture Exchange.

About Syscan International Inc.

Syscan is a world class supply chain solution provider that delivers integrated real-time tracking and tracing systems that improve business efficiency through Radio Frequency Identification (RFID). Its standardized supply chain solutions include traceability, temperature monitoring and quality control methodologies for the food, pharmaceutical and healthcare sectors. Shares of Syscan trade on the TSX Venture Exchange under the symbol SYA. There are currently approximately 47.2 million shares outstanding.

To receive Company press releases, please email valerie@chfir.com and mention Syscan on the subject line.

The TSX Venture Exchange has not reviewed this release and it does not accept responsibility for its adequacy or accuracy.

Contact Information